The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 350:2211-2212 May 20, 2004 Number 21
NextNext

Hepatitis A Vaccine

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Craig, A. S.
-PubMed Citation
To the Editor: Since clinical practice and guidelines for the prevention of hepatitis A by vaccination in Europe differ slightly from those in the United States, we would like to make some comments to complement the article by Craig and Schaffner on this topic (Jan. 29 issue).1 First, hepatitis A vaccines are licensed in Europe for children one year of age or older. Indeed, the safety and immunogenicity of hepatitis A vaccines in young children have been well documented.2 Moreover, although the presence of maternal antibodies diminishes the vaccine antibody response, even in infants the immune system can be adequately . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.